Comparison of Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between Patients with Type 2 Diabetes and Healthy Age Matched Controls.

Not yet recruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

December 31, 2027

Conditions
Microvascular DiseaseMicrovascular ComplicationsDementiaDiabetes Mellitus Type 2Cerebral Hypoperfusion
Interventions
DIAGNOSTIC_TEST

PET

PET imaging will be performed with a Discovery 710 PET/CT scanner (GE Healthcare, Milwaukee, WI, USA). Four 5-minute PET recordings will be performed of each subject within a single scanning session of 70 min. Two consecutive 5-minute scans are conducted of the heart and brain in rest. \[15O\]H2O, is produced on-site (GENtrace, GE, Uppsala, Sweden), and 600 MBq \[15O\]H2O is intravenously injected by an automatic Hidex Radiowater Generator (Hidex, Turku, Finland). To induce heart vasodilation, adenosine is infused (140 g/kg/min) for 6 min and a scan of the heart is repeated. To induce brain vasodilation, 1 g of acetazolamide is infused over 5 min and 15 min later the brain is scanned. Myocardial perfusion is calculated using CarimasCE software version 1.3.1. (Turku, Finland). Cerebral perfusion is calculated using PMOD software (PMOD Technologies, Switzerland).

Trial Locations (1)

2400

Bispebjerg and Frederiksberg Hospital, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Danish Cardiovascular Academy

UNKNOWN

collaborator

Bispebjerg Hospital

OTHER

collaborator

The Dagmar Marshall Foundation

OTHER

collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

University Hospital Bispebjerg and Frederiksberg

OTHER